Literature DB >> 10353611

INK4 cell cycle inhibitors direct transcriptional inactivation of NF-kappaB.

B Wolff1, M Naumann.   

Abstract

The nuclear factor kappaB, a transcription factor regulating the expression of multiple genes including genes essential for cell cycle control, is found in most cells in a dormant state in the cytoplasm bound to the inhibitory family I kappaB via an ankyrin repeat domain. Stimulation of cells with a variety of inducers inactivates I kappaB proteins. The active dimeric NF-kappaB complex, often composed of 50- and 65-kilodalton subunits of the Rel family, translocates into the nucleus, where the NF-kappaBp65 subunit stimulates transcription. Here we report that a family of proteins containing ankyrin repeats, the inhibitors of Cdk4 (INK4) is able to bind NF-kappaBp65. The association of p16INK4 with NF-kappaBp65 is considerable in HeLa- or 293 cells, if the NF-kappaB inhibitor I kappaB alpha is degraded in response to TNFalpha stimulation. Overexpression of INK4 molecules suppresses the transactivational ability of NF-kappaB significantly. In contrast to INK4 proteins, the cell cycle inhibitor p27 enhances NF-kappaB transactivation activity. Thus, the effect of INK4 proteins on NF-kappaB function possibly modifies NF-kappaB mediated transcriptional activation of cell cycle associated factors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10353611     DOI: 10.1038/sj.onc.1202617

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  24 in total

1.  p16INK4a deficiency promotes IL-4-induced polarization and inhibits proinflammatory signaling in macrophages.

Authors:  Céline Cudejko; Kristiaan Wouters; Lucía Fuentes; Sarah Anissa Hannou; Charlotte Paquet; Kadiombo Bantubungi; Emmanuel Bouchaert; Jonathan Vanhoutte; Sébastien Fleury; Patrick Remy; Anne Tailleux; Giulia Chinetti-Gbaguidi; David Dombrowicz; Bart Staels; Réjane Paumelle
Journal:  Blood       Date:  2011-06-02       Impact factor: 22.113

2.  Conditional ablation of Ikkb inhibits melanoma tumor development in mice.

Authors:  Jinming Yang; Ryan Splittgerber; Fiona E Yull; Sara Kantrow; Gregory D Ayers; Michael Karin; Ann Richmond
Journal:  J Clin Invest       Date:  2010-06-07       Impact factor: 14.808

Review 3.  The ankyrin repeat as molecular architecture for protein recognition.

Authors:  Leila K Mosavi; Tobin J Cammett; Daniel C Desrosiers; Zheng-Yu Peng
Journal:  Protein Sci       Date:  2004-06       Impact factor: 6.725

4.  OVCA1 inhibits the proliferation of epithelial ovarian cancer cells by decreasing cyclin D1 and increasing p16.

Authors:  Fandou Kong; Rui Tong; Lingyu Jia; Wei Wei; Xiaoyan Miao; Xinyu Zhao; Wenping Sun; Guang Yang; Chunyan Zhao
Journal:  Mol Cell Biochem       Date:  2011-04-13       Impact factor: 3.396

Review 5.  Regulatory mechanisms of tumor suppressor P16(INK4A) and their relevance to cancer.

Authors:  Junan Li; Ming Jye Poi; Ming-Daw Tsai
Journal:  Biochemistry       Date:  2011-06-06       Impact factor: 3.162

6.  INK4a knockout mice exhibit increased fibrosis under normal conditions and in response to unilateral ureteral obstruction.

Authors:  Jesse M Wolstein; David H Lee; Jennine Michaud; Venessa Buot; Beth Stefanchik; Matthew D Plotkin
Journal:  Am J Physiol Renal Physiol       Date:  2010-09-22

7.  Downregulation of the tumour suppressor p16INK4A contributes to the polarisation of human macrophages toward an adipose tissue macrophage (ATM)-like phenotype.

Authors:  L Fuentes; K Wouters; S A Hannou; C Cudejko; E Rigamonti; T H Mayi; B Derudas; F Pattou; G Chinetti-Gbaguidi; B Staels; R Paumelle
Journal:  Diabetologia       Date:  2011-10-04       Impact factor: 10.122

8.  Genetic evidence for functional dependency of p18Ink4c on Cdk4.

Authors:  Xin-Hai Pei; Feng Bai; Tateki Tsutsui; Hiroaki Kiyokawa; Yue Xiong
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

9.  NFκB induces overexpression of bovine FcRn: a novel mechanism that further contributes to the enhanced immune response in genetically modified animals carrying extra copies of FcRn.

Authors:  Judit Cervenak; Márton Doleschall; Balázs Bender; Balázs Mayer; Zita Schneider; Zoltán Doleschall; Yaofeng Zhao; Zsuzsanna Bősze; Lennart Hammarström; Wolfgang Oster; Imre Kacskovics
Journal:  MAbs       Date:  2013 Nov-Dec       Impact factor: 5.857

Review 10.  NF-kappaB activation in melanoma.

Authors:  Yukiko Ueda; Ann Richmond
Journal:  Pigment Cell Res       Date:  2006-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.